Business · 21/12/2020Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on Wockhardt Ltd. Withdrawal of Nine Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has corrected a notice regarding the withdrawal of approval of nine abbreviated new drug applications (ANDAs) from multiple applicants, including VistaPharm, Inc., after receiving a withdrawal request from the company.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →